Enhanced perigraft angiogenesis prevents prosthetic graft infection.

[1]  J. Coselli,et al.  Options for managing infected ascending aortic grafts. , 2007, The Journal of thoracic and cardiovascular surgery.

[2]  Y. Tabata,et al.  A novel approach to reduce catheter-related infection using sustained-release basic fibroblast growth factor for tissue regeneration in mice , 2007, Heart and Vessels.

[3]  Y. Saiki,et al.  Redo total aortic arch replacement using an extended homograft for graft infection. , 2006, The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi.

[4]  Ying Liu,et al.  Effects of basic fibroblast growth factor microspheres on angiogenesis in ischemic myocardium and cardiac function: analysis with dobutamine cardiovascular magnetic resonance tagging. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[5]  Y. Tabata,et al.  Accelerated wound healing through the incorporation of basic fibroblast growth factor-impregnated gelatin microspheres into artificial dermis using a pressure-induced decubitus ulcer model in genetically diabetic mice. , 2005, British journal of plastic surgery.

[6]  D. Hicklin,et al.  Granulocyte colony‐stimulating factor promotes neovascularization by releasing vascular endothelial growth factor from neutrophils , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  Y. Saiki,et al.  Vacuum-assisted closure system for the treatment of mediastinitis after total aortic arch replacement. , 2005, The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi.

[8]  R. Koerfer,et al.  Clinical outcome of patients with deep sternal wound infection managed by vacuum-assisted closure compared to conventional therapy with open packing: a retrospective analysis. , 2005, The Annals of thoracic surgery.

[9]  Y. Tabata,et al.  Development of biologic coronary artery bypass grafting in a rabbit model: revival of a classic concept with modern biotechnology. , 2004, The Journal of thoracic and cardiovascular surgery.

[10]  Brian H Annex,et al.  Claudication of Vascular Endothelial Growth Factor 121 in Patients With Disabling Intermittent Disease : A Phase II Randomized , Double-Blind , Controlled Study of Adenoviral Delivery Regional Angiogenesis With Vascular Endothelial Growth Factor in Peripheral Arterial , 2003 .

[11]  Masashi Komeda,et al.  Intramyocardial sustained delivery of basic fibroblast growth factor improves angiogenesis and ventricular function in a rat infarct model , 2003, Heart and Vessels.

[12]  J. Shrager,et al.  Omentum is highly effective in the management of complex cardiothoracic surgical problems. , 2003, The Journal of thoracic and cardiovascular surgery.

[13]  W. Kamysz,et al.  Temporin A as a prophylactic agent against methicillin sodium-susceptible and methicillin sodium-resistant Staphylococcus epidermidis vascular graft infection. , 2002, Journal of vascular surgery.

[14]  R. Lederman,et al.  Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial , 2002, The Lancet.

[15]  S. Homma,et al.  Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function , 2001, Nature Medicine.

[16]  Y. Tabata,et al.  Novel Method to Enhance Sternal Healing After Harvesting Bilateral Internal Thoracic Arteries With Use of Basic Fibroblast Growth Factor , 2000, Circulation.

[17]  A. Quyyumi,et al.  Basic fibroblast growth factor in patients with intermittent claudication: results of a phase I trial. , 2000, Journal of the American College of Cardiology.

[18]  J. Coselli,et al.  Management of thoracic aortic graft infections. , 1999, The Annals of thoracic surgery.

[19]  K Walsh,et al.  Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. , 1998, Circulation.

[20]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.

[21]  Y. Ikada,et al.  Enhanced vascularization and tissue granulation by basic fibroblast growth factor impregnated in gelatin hydrogels , 1994 .

[22]  D. Rifkin,et al.  Recent developments in the cell biology of basic fibroblast growth factor , 1989, The Journal of cell biology.

[23]  Ana D. Lopez,et al.  An in vivo model for study of the angiogenic effects of basic fibroblast growth factor. , 1987, Biochemical and biophysical research communications.

[24]  Y. Tabata,et al.  Less-invasive and highly effective method for preventing methicillin-resistant Staphylococcus aureus graft infection by local sustained release of vancomycin. , 2008, The Journal of thoracic and cardiovascular surgery.

[25]  Y. Saiki,et al.  Vacuum-assisted Closure System for the of Mediastinitis after Total Aortic Arch Replacement Treatment , 2005 .

[26]  M. Back,et al.  Use of rifampin-soaked gelatin-sealed polyester grafts for in situ treatment of primary aortic and vascular prosthetic infections. , 2001, The Journal of surgical research.

[27]  T. Maciag,et al.  The heparin-binding (fibroblast) growth factor family of proteins. , 1989, Annual review of biochemistry.